# FDA EIR - Indivior, Inc. - October 19, 2017

Source: https://www.keypedia.com/records/eir/indivior-inc/e6bbda3f-b8b4-47d3-9035-4206b000f5c7

> FDA EIR for Indivior, Inc. on October 19, 2017. Product: RX (Prescription). Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Indivior, Inc.
- Inspection Date: 2017-10-19
- Product Type: RX (Prescription)
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2017-10-19](https://www.keypedia.com/records/483/indivior-inc/ef9dbf71-9783-4e50-bcd9-71a3826dafa7)

## Related Officers

- [other](https://www.keypedia.com/people/kent-hoffman/083e2f25-ce22-4aa8-8ac7-32987018e5b0)
- [company_representative](https://www.keypedia.com/people/sunita-shinde/1a14e486-f325-45a5-84cc-c98f67251e57)
- [other](https://www.keypedia.com/people/aaron-blackledge/5115d36b-fc71-4cae-ae3a-fccb59121f37)
- [company_representative](https://www.keypedia.com/people/karen-hojnowski/57b47a39-46bc-4282-9c92-ae2e4aca6125)
- [company_representative](https://www.keypedia.com/people/mary-decosta/9e27c475-b461-45b3-a75b-dc2c7b4da6dc)

Company: https://www.keypedia.com/companies/indivior-inc/538f0c04-f1ec-40f4-8d9f-90ffbe8c75ab

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c